Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analgesic effect of proximal supplemental obturator nerve block after insufficient femoral nerve block in patients with hip fracture
2015-000078-36Phase 4Terminated
- Sponsor
- Thomas Fichtner Bendtsen
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine in hip fracture, Neck Of Femur Fracture and Hip fracture pain (2 arms), sponsored by Thomas Fichtner Bendtsen. Primary endpoint: Primary: sufficient analgesia at 20 minutes. Started Feb 2015; status: terminated.
02
Drugs
bupivacaine
03
Conditions
hip fractureNeck Of Femur FractureHip fracture pain
Beyond the preview
Go deeper on 2015-000078-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000078-36.